# Altimmune, Inc.: Form 8-K, filed Mar 27, 2024

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: 8-K
- Filed: 2024-03-27
- Accepted by EDGAR: Mar 27, 2024, 07:04 ET
- Period: 2024-03-27
- Accession: 0001326190-24-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000006/alt-20240327x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000006/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000132619024000006/alt-20240327x8k.htm

Filed Mar 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001326190-24-000006. Last ingested by Listed: Nov 14, 2026, 20:51 ET. No prices; not investment advice.
